William Daniel Follas (Dan), President and CEO of XENO, has extensive experience in the laboratory and medical industry. Dan and his brother Evan founded Follas Laboratories in 1979. Starting from the ground up, Dan grew Follas Laboratories into a successful organization serving many medical groups and hospitals in Indiana while employing over 60 people. During this time, Dan focused on finding ways to develop newfound advances in technology and information into practical solutions for patient healthcare. Seeing a need for improved fertility services in Indiana, Dan developed laboratory testing and programs to address this need. Currently he has been involved with the creation of two fertility clinics, the Follas Center for Reproductive Medicine, LLC., and the Advanced Reproduction Institute, LLC. Dan continues to strive for the general improvement of healthcare with his vision, to better understand and address the inflammatory process of disease through XENO diagnostics.
_________________________________________________________
Neil Balgobin, Ph.D. is a senior scientist with extensive experience in Diagnostics, Life Sciences, and Biotech Industries. Neil has intimate knowledge and familiarity with the commercialization of new products as he has been involved in all stages of development, from technology evaluation through research, scale up and launch, as well as process improvements contributing to company profits. Beyond the evaluation and introduction of new technology platforms, Neil also has experience in project management, and product development, from discovery through GMP production. More specifically, Dr. Balgobin has validated and introduced new assays and platforms for Immunoassay and Molecular Diagnostics while maintaining laboratory compliance with the accrediting organizations CAP and CLIA. His work also includes the establishment and implementation of new QC test procedures, and the creation of all GMP manufacturing documents necessary for new products. Neil’s experience is well suited to accomplish XENO Diagnostic’s goals of creating new testing services and products.
